Newsletter Archive
-
03.29.24 -- FDA Issues Final Guidance: Reformulating Drug Products That Contain Carbomers Manufactured With Benzene
3/29/2024
03/29/24 Bioprocess Online Newsletter
-
03.28.24 -- Optimize Your Drug Development With GPS Engineering
3/28/2024
03/28/24 Advancing RNA Newsletter
-
03.28.24 -- Optimize Your Drug Development With GPS Engineering
3/28/2024
03/28/24 Bioprocess Online Newsletter
-
03.27.24 -- Is Your Data Ready For Pharma 4.0?
3/27/2024
03/27/24 Bioprocess Online Newsletter
-
03.27.24 -- Decoding The FDA's Draft Guidance On Computer Software Assurance For Medical Devices & Bio/Pharma
3/27/2024
03/27/24 Bioprocess Online Newsletter
-
03.26.24 -- Optimizing CGT Development: Modular Approaches And Cryopreservation Insights
3/26/2024
03/26/24 Bioprocess Online Newsletter
-
03.26.24 -- Driving Efficiency And Effectiveness In Biopharmaceutical DevelopmentĀ
3/26/2024
03/26/24 Bioprocess Online Newsletter
-
03.25.24 -- Fast-Tracking Process Characterization, Finding Next-Gen Expression Systems, And De-Risking Development
3/25/2024
03/25/24 Bioprocess Online Newsletter
-
03.25.24 -- It's Time To Dethrone CHO When It Comes To mAb Production
3/25/2024
03/25/24 Bioprocess Online Newsletter
-
03.22.24 -- When In The Product's Life Cycle Does Continuous Manufacturing Make Sense?
3/22/2024
03/22/24 Bioprocess Online Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more